The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With Multiple Sclerosis

CompletedNot a drug-phase studyRelapsing MSNCT06987994

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

This trial finished 20 months ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Experemental group

Compared with

  • control group( physical therapy)

What it measured

Main measures

  • Fatigue Severity Score (FSS)

    Baseline and after 4 weeks of intervention

    Fatigue

Other measures (1)

  • Timed Up and Go Test (TUG)

    Baseline and after 4 weeks of intervention

    Walking and mobility

Who could take part

Relapsing MS · 20 to 85 · EDSS 2.0 to 6.5

Show the full criteria

Inclusion criteria

1. individuals diagnosed as MS by a physician 2. Expanded Disability Status Scale (EDSS): 2.0-6.5 3. Patient able to walk with or without the use of unilateral support (e.g., a cane) 4. Patient had not experienced a severe exacerbation of symptoms requiring medical intervention in the previous month 5. subjects had to have the cognitive capacity to assure the requisite cognitive ability 6. spasticity up to 2 on Ashworth scale.

Exclusion criteria

* 1. cognitive disorders hampering the execution of the exercises/assessment, 2. Ability to maintain monopodalic-standing position for 10 s 3. cardiovascular disorders 4. orthopedic disorders that could negatively affect balance 5. uncorrected visual or auditory impairments 6. pregnancy

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This clinical trial aims to evaluate the effectiveness of virtual reality (VR) as a complementary intervention to traditional physical therapy for individuals diagnosed with Multiple Sclerosis (MS). MS is a chronic neurological condition that affects motor and cognitive functions, with fatigue being one of the most common and disabling symptoms. This study will assess whether the use of VR-based applications, in addition to standard physiotherapy, can reduce fatigue and improve functional capacity in individuals with MS. Participants will be randomly assigned to two groups: one group will receive conventional physiotherapy only, while the other will receive VR-based therapy alongside physiotherapy. The intervention period will last four weeks, and both groups will be evaluated using standardized outcome measures before and after the intervention. These include the Fatigue Severity Scale (FSS), the Timed Up and Go (TUG) test, and the 6-Minute Walk Test (6MWT). The study is designed to address a gap in current literature, as no prior research has specifically examined the impact of virtual reality on fatigue and functional performance in MS patients. The findings may provide valuable insights into innovative rehabilitation strategies that enhance patient outcomes and improve quality of life.

Loading reviews and guidelines…

History

    1. Started

      Dec 2024

    2. Main results due

      Feb 2025

    3. Finished

      Feb 2025

    Assembled by software from public sources.